Talbot Financial LLC Has $16.35 Million Position in Stryker Co. (NYSE:SYK)

Talbot Financial LLC trimmed its stake in shares of Stryker Co. (NYSE:SYK - Free Report) by 1.8% in the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 43,920 shares of the medical technology company's stock after selling 802 shares during the quarter. Stryker accounts for 2.0% of Talbot Financial LLC's holdings, making the stock its 16th largest holding. Talbot Financial LLC's holdings in Stryker were worth $16,349,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds and other institutional investors have also modified their holdings of the company. Kohmann Bosshard Financial Services LLC purchased a new position in shares of Stryker in the 4th quarter valued at approximately $25,000. Capital A Wealth Management LLC purchased a new stake in Stryker during the 4th quarter worth about $26,000. Rakuten Securities Inc. lifted its stake in shares of Stryker by 618.2% during the 4th quarter. Rakuten Securities Inc. now owns 79 shares of the medical technology company's stock worth $28,000 after purchasing an additional 68 shares during the period. Centricity Wealth Management LLC purchased a new position in Stryker during the fourth quarter worth approximately $30,000. Finally, BankPlus Trust Department purchased a new position in shares of Stryker in the 4th quarter worth about $33,000. 77.09% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

SYK has been the topic of a number of recent research reports. BTIG Research set a $403.00 price objective on Stryker and gave the stock a "buy" rating in a research note on Monday, April 14th. JMP Securities reaffirmed a "market perform" rating on shares of Stryker in a research report on Monday, May 5th. Sanford C. Bernstein set a $450.00 price target on shares of Stryker in a report on Monday, May 5th. The Goldman Sachs Group set a $422.00 price target on Stryker in a research report on Tuesday, March 4th. Finally, Truist Financial raised their price target on Stryker from $390.00 to $400.00 and gave the company a "hold" rating in a report on Monday, May 5th. Five equities research analysts have rated the stock with a hold rating and fifteen have given a buy rating to the company's stock. According to MarketBeat.com, Stryker has an average rating of "Moderate Buy" and a consensus price target of $427.30.

Stryker Trading Up 0.3%

SYK traded up $1.04 during mid-day trading on Thursday, reaching $383.59. The stock had a trading volume of 371,658 shares, compared to its average volume of 1,329,779. The firm's fifty day simple moving average is $369.68 and its two-hundred day simple moving average is $376.11. The stock has a market capitalization of $146.41 billion, a P/E ratio of 49.43, a P/E/G ratio of 2.93 and a beta of 0.93. Stryker Co. has a 52 week low of $314.93 and a 52 week high of $406.19. The company has a debt-to-equity ratio of 0.59, a quick ratio of 1.32 and a current ratio of 1.95.

Stryker (NYSE:SYK - Get Free Report) last posted its quarterly earnings results on Thursday, May 1st. The medical technology company reported $2.84 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.73 by $0.11. The business had revenue of $5.87 billion for the quarter, compared to analysts' expectations of $5.68 billion. Stryker had a return on equity of 23.58% and a net margin of 13.25%. The firm's quarterly revenue was up 11.9% compared to the same quarter last year. During the same quarter last year, the business earned $2.50 earnings per share. On average, equities analysts predict that Stryker Co. will post 13.47 EPS for the current year.

Stryker Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Thursday, July 31st. Stockholders of record on Monday, June 30th will be given a dividend of $0.84 per share. This represents a $3.36 annualized dividend and a dividend yield of 0.88%. The ex-dividend date is Monday, June 30th. Stryker's dividend payout ratio is 45.41%.

Insider Transactions at Stryker

In other news, Director Ronda E. Stryker sold 200,000 shares of the company's stock in a transaction that occurred on Tuesday, May 6th. The shares were sold at an average price of $376.96, for a total transaction of $75,392,000.00. Following the completion of the sale, the director now owns 3,417,326 shares of the company's stock, valued at approximately $1,288,195,208.96. This represents a 5.53% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. 5.90% of the stock is owned by corporate insiders.

About Stryker

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries.